Only 2 milligrams of the drug – roughly one 50th the size of a pinch of salt – is enough to result in permanent brain damage ...

For people with aneurysmal subarachnoid hemorrhage and anemia, there was no significant neurological benefit from getting red ...

Image classification is one of AI's most common tasks, where a system is required to recognize an object from a given image. Yet real life requires us to recognize not a single standalone object but ...

Boston-based CervoMed (CRVO) said the Phase 2b trial of its neflamapimod did not meet significant statistical thresholds for its primary endpoint of a change in the Clinical Dementia Rating Sum of ...

Neurosurgeons know brain cancer patients live longer and do better if they're able to remove the entire tumor. Now, there's ...

In the RewinD-LB Phase 2b trial, neflamapimod demonstrated a favorable safety and tolerability profile that is consistent with prior clinical studies, with no new safety signal identified.

FRESNO, Calif. (KFSN) -- A Fresno State professor is seeing success by having her students learn with the help of virtual reality. Fresno State Biology Professor and neuroscientist Anahit Hovhannisyan ...

A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queensland has produced successful results in a human clinical trial.

Scientists uncover how TRH neurons suppress hunger by inhibiting AgRP neurons, advancing our understanding of GLP-1-based ...

Researchers say they developed an AI-powered model that can pinpoint remaining cancerous brain tumor parts for potential ...

The tumor cells of highly aggressive glioblastomas grow into the brain like a mycelium. This invasion is promoted by the ...

J.P. Morgan 2025 Healthcare Conference, taking place January 13–16, 2025, in San Francisco, CA ...